"Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology researchers.
The fourth volume of the book brings forth reviews on biomarkers and new drugs used for treating gastrointestinal cancer and breast cancer. The volume also covers the topics of adjuvant therapy, cancer nanodrugs and the role of adiponectin and dicycloplatin in cancer therapy."


Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 4

End User License Agreement (for non-institutional, personal use)

The Advent of New Platforms and Technologies for Personalized Medicine

Biomarkers for Monitoring Response to Therapies and Detection of Acquired Resistance in Advanced Gastrointestinal Cancers

New experimental anticancer agents in the different clinical settings: rationale, mechanism of action, experimental and clinical data

Innovative biological approaches: tumor cell reprogramming and conventional antiestrogen therapy plus immune stimulation; planning of a new antitumoral treatment

Perspectives in Breast Cancer Treatment and Principal New Agents

Foods and Nutrients as Adjuvants in Cancer Chemo-prevention and Treatment

Physical and chemical characteristics of nanodrugs for cancer therapeutic applicationS

Advanced nanocarrier platforms for clinical anticancer drug

Pharmacokinetic characteristics of nanodrugs

Assessing the safety of clinical nanodrug

The challenges and future directions for clinical translation

Clinical Anticancer Nanodrug: Advantages and Challenges

STUCTURAL POLYMORPHISM OF OLIGOMERIC ADIPONECTIN

RECEPTORS AND SIGNALING PATHWAYS OF ADIPONECTIN

ADIPONECTIN AND ITS RECEPTORS IN OBESITY-RELATED CANCER DISEASES

ADIPONECTIN-DERIVED ANTI-CANCER THERAPEUTICS

ALTERNATIVE STRATEGIES FOR ADIPONECTIN REPLACEMENT THERAPIES

Adiponectin-Based Therapeutics for Cancer Treatment

ADJUVANTS IN APPROVED PREVENTIVE AND THERAPEUTIC CANCER VACCINES

POTENTIAL ADJUVANTS FOR USE IN CANCER VACCINES

Adjuvants in Cancer Vaccines - Progress and Challenges

Dicycloplatin, a Platinum-Based Supramolecule with 4 Hydrogen Bonds, is a Promising Chemotherapy Drug

Bentham Science Publishers

"Obesity is a complex health problem, caused by a number of factors such as excessive food intake, lack of physical activity, genetic predisposition, endocrine disorders, medications and psychiatric illnesses. Onset of obesity in both the developing and the developed world has reached epidemic proportions. In response to this, efforts to control and treat obesity have also been vigorously pursued, ranging from raising awareness about lifestyle changes to the discovery and development of safe and effective anti-obesity drugs.
Anti-obesity Drug Discovery and Development is focused on this very important area of healthcare research. The third volume of this series is dedicated to anti-obesity treatments including updates on new therapeutics for obesity, Nesfatin-1 and its therapeutic uses, the role of proteomics in pediatric anti-obesity treatment, the role of oxidative stress in childhood obesity and a review of data on gut microbiota as a treatment option for obesity."


Anti-obesity Drug Discovery and Development: Volume 3

Atta-ur-Rahman

Dr. M. lqbal Choudhary 

"Frontiers in Clinical Drug Research – Anti infectives is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the book series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology.
 
The seventh volume of this series features these interesting reviews:
- Nucleic acid and peptide aptamers as potential antiviral drugs
- Host-directed, antibiotic-adjuvant combination, and antibiotic-antibiotic combination for treating multidrug-resistant (mdr) gram-negative pathogens
- Bioactive substances as anti-infective strategies against clostridioides difficile
- Anti-toxoplasma drug discovery and natural products: a brief overview
- Development of antimalarial and antileishmanial drugs from amazonian biodiversity"


Frontiers in Clinical Drug Research - Anti Infectives: Volume 7

"Advances in Organic Synthesis is a book series devoted to the latest advances in synthetic approaches towards challenging structures. It presents comprehensive articles written by eminent authorities on different synthetic approaches to selected target molecules and new methods developed to achieve specific synthetic transformations. Contributions are written by eminent scientists and each volume is edited by an authority in the field. Advances in Organic Synthesis is essential for all organic chemists in academia and the industry who wish to keep abreast of rapid and important developments in the field.
 
This volume presents the following reviews:
Catalytic Tandem Reactions Triggered by the Introduction of a Carbonyl Function
Synthetic Applications of Bifunctional Knölker Type Iron Complexes as (De)hydrogenation Catalysts
Superelectrophilic Activation of Alkynes, Alkenes, and Allenes
Chitosan and its Derivatives: Synthesis Strategy and Applications
Synthesis of N-Containing Heterocycles via Hypervalent Iodine(III)-Mediated Intramolecular Oxidative Cyclization
Advancements in Ionic Liquids for the Formation of Morita Baylis-Hillman Adducts
 "


Advances in Organic Synthesis: Volume 8

"Frontiers in Clinical Drug Research – Anti infectives is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the eBook series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology.
The fourth volume of this series features reviews that cover a variety of topics including: 
-Strategies to prolong antibiotic life
-Catalytic antibodies for targeting rabies and influenza viruses
-Antiviral therapies for arenaviruses
-The role of steroids in viral infections
-Monoclonal antibody manufacturing processes
-Prevention and eradication of biofilms in medical devices"


Frontiers in Clinical Drug Research - Anti Infectives: Volume 4

"Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.
 
The fifth volume of this series features reviews that cover the following topics:
-drug treatment for spinal cord injury
-action tremors
-natural products for Alzheimer’s disease treatment
-non pharmacological approaches towards pain management
-biosensors for detecting neurodegenerative diseases
-NMDA receptor targeting
-alkaloid antidepressants"


Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 5

"Frontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest and the most important advances in anti-cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. Each volume is devoted to the major advances in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.
The eighth volume of the series features chapters covering the following topics:
- T cells in gastrointestinal cancers
- The pharmacology of adjudin – a male contraceptive with anti-cancer properties
- Manipulating the tumor microenvironment
- Treatment of hepatocellular carcinoma
- Gold-based compounds as potential anti-cancer drug candidates
- Oral nanostructure drug delivery for anti-cancer treatment"


Frontiers in Anti-Cancer Drug Discovery: Volume 8

"Frontiers in Clinical Drug Research – Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases – diabetes and obesity. The scope of the series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs affecting endocrine and metabolic processes linked with diabetes and obesity. Reviews in this series also include research on specific receptor targets and pre-clinical / clinical findings on novel pharmaceutical agents. Frontiers in Clinical Drug Research – Diabetes and Obesity is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of diabetes and obesity research.
 
 
 
The fifth volume of this series features 5 reviews which are informative guides to therapy and drug administration in diabetes and metabolic syndrome, for both the medical specialist and the pharmacologist.
 
 
 
-Metabolic syndrome in schizophrenia
 
-Insulin therapy and foetoplacental endothelial dysfunction in gestational diabetes mellitus
 
-Insights on diabetes, oxidative stress and antioxidant therapeutic strategies
 
-Administration of nano drugs in the treatment of diabetes mellitus
 
-SGLT-2 inhibitors"


Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 5

"Genome science or genomics is essential to advancing knowledge in the fields of biology and medicine. Specifically, researchers learn about the molecular biology behind genetic expression in living organisms and related methods of treating human genetic diseases (including gene therapy). Advances in Genome Science is an e-book series which provides a multi-disciplinary view of some of the latest developments in genome research, allowing readers to capture the essence and diversity of genomics in contemporary science.
 
The fourth volume of this ebook series features a selection of articles covering the genetic mechanisms in the development of specific plants (orchids, thale cress), Prader-Willi Syndrome, enzyme genetics (tyrosine kinase inhibitors and fungal laccases) and much more."


Genes in Health and Disease

"Recent Advances in Analytical Techniques is a series of updates in techniques used in chemical analysis. Each volume presents a selection of chapters that explain different analytical techniques and their use in applied research. Readers will find updated information about developments in analytical methods such as chromatography, electrochemistry, optical sensor arrays for pharmaceutical and biomedical analysis. 
The third volume of the series features seven reviews on a variety of techniques: 
 
Chiral Analysis of Methamphetamine and Related Controlled Substances in Forensic Science
Low-cost feedstocks for biofuels and high value added products production: Using multi-parameter flow cytometry as a tool to enhance the process efficiency
Recent Trends in the Application of Ionic Liquids for Micro Extraction Techniques 
Electrospun Nanofibers: Functional and Attractive Materials for the Sensing and Separation Approaches in Analytical Chemistry 
Neutron Activation Analysis: An Overview
Non-commercial Polysaccharides-based Chiral Selectors in Enantioselective Chromatography 
Ru(II)-polypyridyl Complexes as Potential Sensing Agents for Cations and Anions 
 "


Recent Advances in Analytical Techniques: Volume 3

Sibel A. Ozkan

"Frontiers in Clinical Drug Research – HIV is a book series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of acquired immune deficiency syndrome (AIDS) and other disorders associated with human immunodeficiency virus (HIV) infection. The scope of the book series covers a range of topics including the medicinal chemistry and pharmacology of natural and synthetic drugs employed in the treatment of AIDS (including HAART) and resulting complications, and the virology and immunological study of HIV and related viruses. Frontiers in Clinical Drug Research – HIV is a valuable resource for pharmaceutical scientists, clinicians and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in HIV/AIDS research.
The fourth volume of this series features 5 chapters that cover these topics: 
- Design and Synthesis of HIV-1 Protease Inhibitors
- Potential Magnetic Nanotherapeutics for Management of neuroAIDS
- Syntheses of FDA Approved Integrase Inhibitor HIV Drugs and Improved Manufacturing using Flow Processing
- The Development and Clinical Progress on Chemokine Receptor-Based HIV Entry Inhibitors
- Sexually Transmitted Co-infections in Persons Living with HIV"


Sepetiniz

Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 4

$ 89.00

description_of_book

Ek Bilgi

Yazarlar Hakkında

Atta-ur-Rahman

Anti-obesity Drug Discovery and Development: Volume 3

Frontiers in Clinical Drug Research - Anti Infectives: Volume 7

Advances in Organic Synthesis: Volume 8

Frontiers in Clinical Drug Research - Anti Infectives: Volume 4

Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 5

Frontiers in Anti-Cancer Drug Discovery: Volume 8

Frontiers in Clinical Drug Research - Diabetes and Obesity: Volume 5

Genes in Health and Disease

Recent Advances in Analytical Techniques: Volume 3

Frontiers in Clinical Drug Research - HIV: Volume 4

Atta-ur-Rahman